Book Description
Drs. Jay S. Duker and Michelle C. Liang have assembled a prestigious group of contributors who pool their collective expertise in this comprehensive book. Anti-VEGF Use in Ophthalmology is split into two sections with the first providing the history of VEGF and an overview of anti-VEGF agents and different routes of drug delivery, as it is important for eye care providers to be familiar with up-to-date aspects of the medications and indications for use.
The second section details the clinical uses of anti-VEGF agents in numerous ocular diseases, from the anterior segment including cornea and glaucoma to uveitis and various retinal and choroidal diseases. Each chapter in this section summarizes the disease process and utilizes high-quality ocular imaging to demonstrate the therapeutic use of the anti-VEGF agents.
Some of the topics covered in Anti-VEGF Use in Ophthalmology:
- Neovascular Age-Related Macular Degeneration
- Proliferative Diabetic Retinopathy
- Retinal Vein Occlusion
- Uveitis
- Neovascular Glaucoma
- Macular Edema
- Retinopathy of Prematurity
- Corneal Disease
More Information
Contents
Dedication
About the Editors
Contributing Authors
Introduction
Section I Overview of Anti-Vascular Endothelial
Growth Factor Agents
Chapter 1 Vascular Endothelial Growth Factor:
Background and History
Anthony Joseph, MD and Ehsan Rahimy, MD
Chapter 2 Development of Anti-Vascular Endothelial
Growth Factor Agents
Maya H. Maloney, MD and Sophie J. Bakri, MD
Chapter 3 Available Anti-Vascular Endothelial
Growth Factor Agents
Angeline Mariani Derham, MD and David M. Brown, MD, FACS
Chapter 4 Agents Under Study
Ehsan Rahimy, MD; Elham Rahimy, BS;
and Anthony Joseph, MD
Chapter 5 Intravitreal Delivery
Nora Muakkassa, MD; Kendra Klein, MD; and
Elias Reichel, MD
Chapter 6 Sustained Delivery Options Under Study
Michael N. Cohen, MD; Chirag P. Shah, MD, MPH; and
Jeffrey S. Heier, MD
Section II Use of Anti-Vascular Endothelial
Growth Factor Agents in Clinical Practice
Chapter 7 Neovascular Age-Related Macular Degeneration
Michael D. Lewen, MD and Andre J. Witkin, MD
Chapter 8 Choroidal Neovascularization,
Not Age-Related Macular Degeneration
Darin R. Goldman, MD
Chapter 9 Diabetic Macular Edema
Emily D. Cole, BS; Eduardo A. Novais MD; and
Nadia K. Waheed, MD, MPH
Chapter 10 Proliferative Diabetic Retinopathy
Sabin Dang, MD and Chirag P. Shah, MD, MPH
Chapter 11 Retinal Vein Occlusion
Shilpa Desai, MD and Caroline R. Baumal, MD
Chapter 12 Uveitis
Lana M. Rifkin, MD
Chapter 13 Retinopathy of Prematurity
Nikisha A. Kothari, MD and Audina M. Berrocal, MD
Chapter 14 Miscellaneous Retinal and Choroidal Diseases
Michael D. Tibbetts, MD
Chapter 15 Neovascular Glaucoma
Manik Goel, MD and Joel S. Schuman, MD, FACS
Chapter 16 Glaucoma Surgery
Jessica J. Moon, MD and Cynthia Mattox, MD
Chapter 17 Anterior Segment Diseases
Alessandro Abbouda, MD; Bijan Khaksari, BA; and
Pedram Hamrah, MD, FRCS
Financial Disclosures
IndexAbout the Editors
Michelle C. Liang, MD, is Assistant Professor of Ophthalmology at the Tufts University School of Medicine and a vitreoretinal specialist at the New England Eye Center in Boston, Massachusetts. She graduated with honors from Johns Hopkins University with a degree in Biology and earned her medical degree from the University at Buffalo School of Medicine and Biomedical Sciences. She performed her residency in ophthalmology at the New England Eye Center at Tufts Medical Center and went on to complete a vitreoretinal surgery fellowship at the New England Eye Center and Ophthalmic Consultants of Boston.
Dr. Liang has authored numerous scientific papers and book chapters and has presented at several national meetings. She treats all conditions of the retina and vitreous, including macular degeneration, vitreomacular disorders, diabetic retinopathy, retinal vascular disorders, retinal detachment, and cataract complications. Her research interests include retinal imaging and new therapies for macular degeneration, diabetic macular edema, and other diseases. Dr. Liang is a board-certified member of the American Board of Ophthalmology and a member of the American Academy of Ophthalmology and American Society of Retinal Specialists.